Soleno Therapeutics (SLNO) Q3 2023 Earnings

7NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.95
-0.83
-0.7
-0.58

Details

Expected EPS
-0.58
Actual EPS
-0.95
Surprise EPS
-0.37
Surprise Percent
+63.79%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.95 per share for Q3 2023.

0 Comments

Share your thoughts